Accuray ARAY
NASDAQ ARAY
$0.29 0.00 (-0.81%)
As of: Aug 20, 2026 · 3:59 PM EDT

Accuray (ARAY) Non Operating Interest Expenses (2024 - 2025)

Accuray (ARAY) posted quarterly Non Operating Interest Expenses of $284000.0 for Q3 2025, up 273.68% year-over-year from $76000.0 in Q3 2024, and up 273.68% quarter-over-quarter from $76000.0 in Q3 2024.

Accuray (ARAY) Non Operating Interest Expenses (2024 - 2025) Analysis & Trends

Accuray's Non Operating Interest Expenses history runs 2 years deep, the most recent figure standing at $284000.0 for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 351.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 141.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 176.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 96.00 Mn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 114.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -110.42 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 15.80 Mn
10 Accuray 35.97 Mn -3.73 Mn 25.29 Mn 8.45 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 284,000.00
Sep 30, 2024 76,000.00